Impact of genotype on adverse effects during treatment with metoprolol: A prospective clinical study

Abstract

CYP2D6 genotype-derived phenotype was not significantly associated with a propensity for adverse effects to develop during treatment with metoprolol. However, the results concerning tolerability of metoprolol in PMs were inconclusive because of the small number of PMs enrolled.